Logo do repositório
 
Publicação

SRC inhibition prevents P-cadherin mediated signaling and function in basallike breast cancer cells

dc.contributor.authorRibeiro, Ana Sofia
dc.contributor.authorNobre, Ana Rita
dc.contributor.authorMendes, Nuno
dc.contributor.authorAlmeida, João
dc.contributor.authorVieira, André Filipe
dc.contributor.authorSousa, Bárbara
dc.contributor.authorCarvalho, Filomena Almeida
dc.contributor.authorMonteiro, Joana
dc.contributor.authorPolónia, António
dc.contributor.authorFonseca, Martina
dc.contributor.authorSanches, João Miguel
dc.contributor.authorSantos, Nuno C.
dc.contributor.authorSeruca, Raquel
dc.contributor.authorParedes, Joana
dc.date.accessioned2019-03-27T12:04:21Z
dc.date.available2019-03-27T12:04:21Z
dc.date.issued2018
dc.description© The Author(s). 2018. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.pt_PT
dc.description.abstractBACKGROUND: Basal-like breast cancer (BLBC) is a poor prognosis subgroup of triple-negative carcinomas that still lack specific target therapies and accurate biomarkers for treatment selection. P-cadherin is frequently overexpressed in these tumors, promoting cell invasion, stem cell activity and tumorigenesis by the activation of Src-Family kinase (SRC) signaling. Therefore, our aim was to evaluate if the treatment of BLBC cells with dasatinib, the FDA approved SRC inhibitor, would impact on P-cadherin induced tumor aggressive behavior. METHODS: P-cadherin and SRC expression was evaluated in a series of invasive Breast Cancer and contingency tables and chi-square tests were performed. Cell-cell adhesion measurements were performed by Atomic Force Microscopy, where frequency histograms and Gaussian curves were applied. 2D and 3D cell migration and invasion, proteases secretion and self-renew potential were evaluated in vitro. Student's t-tests were used to determine statistically significant differences. The cadherin/catenin complex interactions were evaluated by in situ proximity-ligation assay, and statistically significant results were determined by using Mann-Whitney test with a Bonferroni correction. In vivo xenograft mouse models were used to evaluate the impact of dasatinib on tumor growth and survival. ANOVA test was used to evaluate the differences in tumor size, considering a confidence interval of 95%. Survival curves were estimated by the Kaplan-Meier's method, using the log-rank test to assess significant differences for mice overall survival. RESULTS: Our data demonstrated that P-cadherin overexpression is significantly associated with SRC activation in breast cancer cells, which was also validated in a large series of primary tumor samples. SRC activity suppression with dasatinib significantly prevented the in vitro functional effects of P-cadherin overexpressing cells, as well as their in vivo tumorigenic and metastatic ability, by increasing mice overall survival. Mechanistically, SRC inhibition affects P-cadherin downstream signaling, rescues the E-cadherin/p120-catenin complex to the cell membrane, recovering cell-cell adhesion function. CONCLUSIONS: In conclusion our findings show that targeting P-cadherin/SRC signaling and functional activity may open novel therapeutic opportunities for highly aggressive and poor prognostic basal-like breast cancer.pt_PT
dc.description.sponsorshipThis work was funded by Laço Grant 2014, by FEDER - Fundo Europeu de Desenvolvimento Regional funds through the COMPETE 2020 – Operacional Programme for Competitiveness and Internationalisation (POCI), Portugal 2020, and by FCT - Fundação para a Ciência e a Tecnologia/ Ministério da Ciência, Tecnologia e Ensino Superior under the projects PTDC/SAU-GMG/120049/2010-FCOMP-01-0124-FEDER-021209, PEst-C/SAU/LA0003/2013, NORTE-01-0145-FEDER-000029 and POCI-01-0145-FEDER-016390. FCT funded the research grants of ASR (SFRH/BPD/75705/2011), ARN (SFRH/BD/100380/2014), BS (SFRH/BPD/104208/2014), AFV (SFRH/BPD/90303/2012), as well as JP with Programa IFCT 2013 (FCT Investigator). IPATIMUP integrates the i3S Research Unit, which is partially supported by FCT in the framework of the project “Institute for Research and Innovation in Health Sciences” (POCI-01-0145-FEDER-007274)pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationCell Commun Signal. 2018 Nov 7;16(1):75pt_PT
dc.identifier.doi10.1186/s12964-018-0286-2pt_PT
dc.identifier.issn1478-811X
dc.identifier.urihttp://hdl.handle.net/10451/37707
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherBMCpt_PT
dc.relationFCOMP-01-0124-FEDER-021209pt_PT
dc.relationNORTE-01-0145-FEDER-000029pt_PT
dc.relationPOCI-01-0145-FEDER-016390pt_PT
dc.relationADHESION, DIFFERENTIATION AND INVASION: DIFFERENT PROCESSES, COMMON CADHERIN PLAYERS
dc.relationOn the Mechanisms of Early-dissemination, Dormancy and Metastasis - Early-dissemination, invasion and dormancy escape: different processes, common players
dc.relationP-CADHERIN AS A REGULATOR OF EPITHELIAL CELL POLARITY AND STEM CELL DIVISION AND THE SIGNIFICANCE OF ITS OVEREXPRESSION IN BRCA1-ASSOCIATED BASAL-LIKE BREAST CARCINOMAS
dc.relation.publisherversionhttps://biosignaling.biomedcentral.com/pt_PT
dc.relation.publisherversionhttps://link.springer.com/journal/12964pt_PT
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt_PT
dc.subjectP-cadherinpt_PT
dc.subjectDasatinibpt_PT
dc.subjectBasal-like breast cancerpt_PT
dc.subjectSrc family kinasept_PT
dc.titleSRC inhibition prevents P-cadherin mediated signaling and function in basallike breast cancer cellspt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.awardTitleADHESION, DIFFERENTIATION AND INVASION: DIFFERENT PROCESSES, COMMON CADHERIN PLAYERS
oaire.awardTitleOn the Mechanisms of Early-dissemination, Dormancy and Metastasis - Early-dissemination, invasion and dormancy escape: different processes, common players
oaire.awardTitleP-CADHERIN AS A REGULATOR OF EPITHELIAL CELL POLARITY AND STEM CELL DIVISION AND THE SIGNIFICANCE OF ITS OVEREXPRESSION IN BRCA1-ASSOCIATED BASAL-LIKE BREAST CARCINOMAS
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/COMPETE/PEst-C%2FSAU%2FLA0003%2F2013/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/COMPETE/PTDC%2FSAU-GMG%2F120049%2F2010/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT//SFRH%2FBPD%2F75705%2F2011/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/FARH/SFRH%2FBD%2F100380%2F2014/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT//SFRH%2FBPD%2F90303%2F2012/PT
oaire.citation.issue1pt_PT
oaire.citation.startPage75pt_PT
oaire.citation.titleCell Communication and Signalingpt_PT
oaire.citation.volume16pt_PT
oaire.fundingStreamCOMPETE
oaire.fundingStreamCOMPETE
oaire.fundingStreamFARH
person.familyNameCarvalho
person.familyNameSantos
person.givenNameFilomena
person.givenNameNuno
person.identifier.ciencia-id4615-4AEC-8D91
person.identifier.ciencia-idCD13-5E3A-A3C5
person.identifier.orcid0000-0001-6088-3894
person.identifier.orcid0000-0002-0580-0475
person.identifier.ridM-9202-2013
person.identifier.ridN-7248-2013
person.identifier.scopus-author-id7103069694
person.identifier.scopus-author-id55940818300
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublication547cb993-880c-4608-b1e0-493ad469eecb
relation.isAuthorOfPublication4656d912-5a2d-4c80-8921-2bcba3aa441a
relation.isAuthorOfPublication.latestForDiscovery4656d912-5a2d-4c80-8921-2bcba3aa441a
relation.isProjectOfPublicationd746b14c-8ae5-42cb-b1a1-fa114fb79db5
relation.isProjectOfPublication154df3f6-072b-4149-976e-af5081a97d5b
relation.isProjectOfPublicatione94fdfcc-f6d4-475f-8fb4-3ca338d305b8
relation.isProjectOfPublication3f2c912e-2214-4927-be3c-e26b16575059
relation.isProjectOfPublication55500f20-c042-4335-bead-ffd76bfba99e
relation.isProjectOfPublication.latestForDiscovery55500f20-c042-4335-bead-ffd76bfba99e

Ficheiros

Principais
A mostrar 1 - 1 de 1
A carregar...
Miniatura
Nome:
SRC_inhibition.pdf
Tamanho:
13.83 MB
Formato:
Adobe Portable Document Format
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
1.2 KB
Formato:
Item-specific license agreed upon to submission
Descrição: